Prognostic Value of Baseline and Change of Soluble Suppression of Tumorigenicity-2 in Light Chain Cardiac Amyloidosis

被引：0
|
作者：
Xin, Anran
Li, Xinqing
Huang, Yan
Zhuang, Xiaofeng
Zhao, Xuemei
Wang, Jinxi
Zhou, Ping
Zhang, Jian
Zhang, Yuhui
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4142598
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4142598
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure
    Alladina, Jehan
    Levy, Sean D.
    Cho, Josalyn L.
    Brait, Kelsey L.
    Rao, Sowmya R.
    Camacho, Alexander
    Hibbert, Kathryn A.
    Harris, R. Scott
    Medoff, Benjamin D.
    Januzzi, James L.
    Thompson, B. Taylor
    Bajwa, Ednan K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (10) : 1257 - 1265
  • [22] Soluble suppression of tumorigenicity-2 predicts pneumonia in patients with inhalation injury: Results of a pilot study*
    Ruiz-Castilla, Mireia
    Dos Santos, Bruce
    Vizcaino, Claudia
    Baena, Jacinto
    Guilabert, Patricia
    Marin-Corral, Judith
    Masclans, Joan R.
    Roca, Oriol
    Barret, Juan P.
    BURNS, 2021, 47 (04) : 906 - 913
  • [23] Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis
    Perlini, Stefano
    Salinaro, Francesco
    Musca, Francesco
    Mussinelli, Roberta
    Boldrini, Michele
    Raimondi, Ambra
    Milani, Paolo
    Foli, Andrea
    Cappelli, Francesco
    Perfetto, Federico
    Palladini, Giovanni
    Rapezzi, Claudio
    Merlini, Giampaolo
    JOURNAL OF HYPERTENSION, 2014, 32 (05) : 1121 - 1131
  • [24] Prognostic Value of Different Definitions of Iron Deficiency in Light Chain Cardiac Amyloidosis Patients
    Li, Xinqing
    Xin, Anran
    Huang, Yan
    Zhuang, Xiaofeng
    Zhao, Xuemei
    Wang, Jinxi
    Zhou, Ping
    Zhang, Yuhui
    Zhang, Jian
    CIRCULATION, 2024, 150
  • [25] The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
    Miao, Fujia
    Tang, Chunxiang
    Ren, Guisheng
    Guo, Jinzhou
    Zhao, Liang
    Xu, Weiwei
    Zhou, Xiyang
    Zhang, Longjiang
    Huang, Xianghua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
    Sun, Yutong
    Zhao, Qinghao
    Liu, Yang
    Wen, Lei
    Dou, Xuelin
    Lu, Jin
    Liu, Jian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [27] Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
    Cui, Yameng
    Qi, Xin
    Huang, Anan
    Li, Jiao
    Hou, Wenguang
    Liu, Keqiang
    MEDICAL SCIENCE MONITOR, 2018, 24 : 5139 - 5146
  • [28] Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients
    Numan, L.
    Aarts, E.
    Ramjankhan, F.
    Van der Meer, M. G.
    Oerlemans, M.
    De Jonge, N.
    Oppelaar, A.
    Kemperman, H.
    Asselbergs, F.
    Van Laake, L. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S364 - S365
  • [29] Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
    Zhang, Yang
    Xiao, Ying
    Liu, Yongtai
    Fang, Quan
    Tian, Zhuang
    Li, Jian
    Zhou, Daobin
    Xie, Zhongpeng
    Dong, Ruijia
    Zhang, Shuyang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 7
  • [30] Long-Term and Short-Term Prognostic Value of Circulating Soluble Suppression of Tumorigenicity-2 Concentration in Chronic Heart Failure: A Systematic Review and Meta-Analysis
    Dong, Guoqi
    Chen, Hao
    Zhang, Hongru
    Gu, Yihuang
    CARDIOLOGY, 2021, 146 (04) : 433 - 440
12345